# Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

> **NCT00286442** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 527 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Alogliptin and metformin
- **DRUG:** Alogliptin and metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00286442
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286442, "Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00286442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*